which has been set up in order to realize more efficient and highly specialized clinical research functions, with operations scheduled to commence from October 1, 2004.

CCRC has been established as the new global center for clinical research carried out by members of the Chugai group. By concentrating to CCRC all clinical research from trials conducted in the US, EU and Japan, we will be able to further strengthen relations between the three operative sites, shorten the development periods and achieve greater overall efficiency in global development.

The main functions of CCRC will be statistical analysis and data management, clinical pharmacology, GCP management and domestic monitoring. However, through centering to CCRC all clinical-related work possible for outsourcing, we will also be able to create improved efficiency in work as well as lower operational costs.

Following its strategic alliance with F. Hoffmann-La Roche, Chugai has been expanding its market presence in order to achieve the level of growth required of a top domestic pharmaceutical company that boasts a global business infrastructure.

With the foundation of the CCRC, in addition to fortifying current global clinical development, Chugai hopes to establish even stronger business structures that will subsequently improve both the quality and speed of development.